[HTML][HTML] Sacubitril/valsartan in heart failure with reduced ejection fraction: real-world experience from Italy (the REAL. IT study)
A Di Lenarda, G Di Gesaro, FM Sarullo, D Miani… - Journal of Clinical …, 2023 - mdpi.com
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
[PDF][PDF] Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study)
A Di Lenarda, G Di Gesaro, FM Sarullo, D Miani… - J. Clin. Med, 2023 - researchgate.net
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study)
A Di Lenarda, G Di Gesaro… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study).
A Di Lenarda, G Di Gesaro, FM Sarullo… - Journal of Clinical …, 2023 - search.ebscohost.com
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
[引用][C] Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study)
A Di Lenarda, G Di Gesaro, FM Sarullo… - JOURNAL OF …, 2023 - research.unipg.it
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World
Experience from Italy (the REAL.IT Study) IRIS IRIS Home Sfoglia Macrotipologie & …
Experience from Italy (the REAL.IT Study) IRIS IRIS Home Sfoglia Macrotipologie & …
[PDF][PDF] Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study)
A Di Lenarda, G Di Gesaro, FM Sarullo, D Miani… - J. Clin. Med, 2023 - academia.edu
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study)
A Di Lenarda, G Di Gesaro, FM Sarullo… - Journal of Clinical …, 2023 - search.proquest.com
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study)
AD Lenarda, GD Gesaro, FM Sarullo… - Journal of Clinical …, 2023 - jglobal.jst.go.jp
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World
Experience from Italy (the REAL.IT Study) | Article Information | J-GLOBAL Art J-GLOBAL ID:202302223832816713 …
Experience from Italy (the REAL.IT Study) | Article Information | J-GLOBAL Art J-GLOBAL ID:202302223832816713 …
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study).
A Di Lenarda, G Di Gesaro, FM Sarullo… - Journal of Clinical …, 2023 - europepmc.org
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
[HTML][HTML] Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL. IT Study)
A Di Lenarda, G Di Gesaro, FM Sarullo… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
Sacubitril/valsartan reduces heart failure (HF)-related hospitalizations and cardiovascular
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …
mortality in PARADIGM-HF and has become a foundational treatment for HF with reduced …